by Alex Bajjon | Aug 1, 2015 | UK
Warner-Lambert is the proprietor of European Patent 0934061 which claims “Use of Pregablin for the preparation of a pharmaceutical composition for treating pain”. Pregablin is also used for the treatment of generalised anxiety disorder and epilepsy, although treatment...
by George Schlich | May 1, 2015 | EPO
Background Applicants wishing to obtain patent protection in more than one country have various options for doing so. One strategy is to file a first application at, say, the UK Intellectual Property Office (UKIPO) or the European Patent Office (EPO), and then file a...
by Alex Bajjon | May 1, 2015 | EPO, UPC
Introduction The Court costs for the Unified Patent Court seem significantly higher than those of the UK High Court, with the cost for actions for infringement at €11,000 and revocation actions (including counterclaims) at €20,000. In addition to this, for claims with...
by David Eyre | May 1, 2015 | Briefings
Developments in the media across the world mean that recognition of a trade mark is ever easier. However, the Supreme Court has considered whether gaining such a reputation is the same as gaining goodwill in a trade mark. Goodwill is the quality attached to a trade...
by David Eyre | Mar 1, 2015 | Briefings
WEDNESDAY 25 MARCH 2015 FROM 5.15PM Where does Europe stand on the patentability of huESCs? Can this be influenced for a broader scope of protection in support of innovative technology and future life changing therapies. You are invited to participate in an open,...
Recent Comments